Zhongchao (NASDAQ:ZCMD) Stock Gets Downgrade from Wall Street Zen

Zhongchao (NASDAQ:ZCMD – Get Free Report) was downgraded by equities researchers at Wall Street Zen from a “sell” rating to a “strong sell” rating in a report released on Saturday, Wall Street Zen reports.

Separately, Weiss Ratings downgraded shares of Zhongchao from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Friday, September 25th. One investment analyst has rated the stock with a Sell rating. According to MarketBeat.com, Zhongchao currently has an average rating of “Sell”.

View Our Latest Stock Analysis on Zhongchao

Zhongchao Stock Performance

Zhongchao stock opened at $1.02 on Friday. The company’s 50 day moving average is $1.59 and its two-hundred day moving average is $183.68. Zhongchao has a 52-week low of $1.02 and a 52-week high of $1,443.36.

Zhongchao Company Profile

(Get Free Report)

Zhongchao Inc (NASDAQ: ZCMD) is a China-based healthcare services company focused on medical education and patient management. Through its operating subsidiaries, the company provides services intended to support healthcare professionals, patients and pharmaceutical or medical-product companies, with an emphasis on oncology and other chronic disease areas.

Zhongchao’s medical education activities have included online and offline educational programs, academic conferences, seminars and other professional training initiatives for physicians and healthcare providers.

See Also

Receive News & Ratings for Zhongchao Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zhongchao and related companies with MarketBeat.com's FREE daily email newsletter.